Aleisa AM et al. |
Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17973863
|
Wikoff WR et al. |
Metabolomics identifies perturbations in human disorders of propionate metabolism. |
2007 |
Clin. Chem. |
pmid:17951291
|
Safarinejad MR et al. |
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. |
2007 |
J. Urol. |
pmid:17706714
|
Orlandi A et al. |
Propionyl-L-carnitine prevents age-related myocardial remodeling in the rabbit. |
2007 |
J. Cardiovasc. Pharmacol. |
pmid:17703133
|
de Sotomayor MA et al. |
l-carnitine and its propionate: improvement of endothelial function in SHR through superoxide dismutase-dependent mechanisms. |
2007 |
Free Radic. Res. |
pmid:17654045
|
Leipälä JA et al. |
Protection of the reperfused heart by L-propionylcarnitine. |
1991 |
J. Appl. Physiol. |
pmid:1757378
|
la Marca G et al. |
Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. |
2007 |
Clin. Chem. |
pmid:17510301
|
Alvarez de Sotomayor M et al. |
Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. |
2007 |
J. Vasc. Res. |
pmid:17483601
|
Pickard R |
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. |
2007 |
Eur. Urol. |
pmid:17478036
|
Salonia A |
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. |
2007 |
Eur. Urol. |
pmid:17478035
|
Morano S et al. |
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. |
2007 |
Eur. Urol. |
pmid:17478034
|
Montisci R et al. |
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. |
2007 |
Clin Ther |
pmid:17379056
|
Lagioia R et al. |
Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina. |
1992 |
Int. J. Cardiol. |
pmid:1737667
|
Perna AF et al. |
L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis. |
2007 Jan-Feb |
J. Nephrol. |
pmid:17347975
|
Al-Majed AA |
Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats. |
2007 |
Basic Clin. Pharmacol. Toxicol. |
pmid:17309516
|
Orlandi A et al. |
Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. |
2007 |
J. Biol. Chem. |
pmid:17178728
|
Loffredo L et al. |
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. |
2006 |
J. Vasc. Surg. |
pmid:16950429
|
Al-Majed AA et al. |
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16895547
|
Signorelli SS et al. |
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease. |
2006 |
Kidney Blood Press. Res. |
pmid:16809937
|
Signorelli SS et al. |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. |
2006 |
Drugs Aging |
pmid:16608381
|